1. Comprehensive Review on Alzheimer's Disease: causes and Treatment;Breijyeh;Molecules.,2020
2. Alzheimer disease immunotherapeutics: then and now;Jindal;Hum. Vaccin. ImmunOther,2014
3. Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging;Lowe;J. Preventive Alzheimer's Disease,2021
4. Donanemab in Japanese Patients with Early Alzheimer's Disease: subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial;Sato;Neurological Therapy,2024
5. Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer's disease;Shukla;J. Basic Clin. Physiol. Pharmacol.,2023